This pattern may reflect receptor adaptation, where sustained CXXC5 inhibition leads to compensatory changes in the signaling network
GHK-Cu is in a category of its own compared to other peptides like BPC-157 or Semax, it does not address inflammation or cognitive function in the same way
Abdullahi, M., Raji, A., & Samuel, D
Kenneth McCall, published a paper in 2025 finding that compounded GLP-1s were linked to higher rates of adverse effects than non-compounded products between 2018 and 2024, including more abdominal pain, diarrhea, and nausea
The peptides antioxidant and repair-support properties may help support recovery and resilience
Injections are typically continued 2 to 3 times weekly, if directed